To compare the efficacy of continuous infusion and intermittent bonus of 0.2% Ropivacaine in Adductor canal block for postoperative analgesia in total knee replacement surgeries
Phase 4
- Conditions
- Health Condition 1: M170- Bilateral primary osteoarthritis of knee
- Registration Number
- CTRI/2024/02/062254
- Lead Sponsor
- Tata Motors Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient’s informed consent
Age of patient- 55-75years
Patients undergoing Total Knee Replacement Surgery
ASA grade I,II
Exclusion Criteria
Patient’s refusal
Any bleeding disorder or coagulopathies
ASA grade III,IV
Allergy/contraindication to any drugs used in study
Chronic opioid user
Any neurologic deficit
Failed neuraxial anaesthesia
Infection/inflammation at site of injection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the analgesic efficacy of intermittent bolus versus continuous infusion of Ropivacaine in adductor canal block using Numerical Rating scaleTimepoint: Pain shall be assessed at 0,4,8,12,24 hours and 0.25% Ropivacaine 20ml shall be given in adductor canal if Numerical Rating Scale is more than 3 at any given time.
- Secondary Outcome Measures
Name Time Method To compare the motor block between the two groups using the Modified Bromage scale <br/ ><br>Timepoint: The patients will be assessed for motor blockade every 6 hours interval for 24 hours postoperatively by the Modified Bromage Scale.;To compare the total amount of Ropivacaine consumed between the study groupsTimepoint: Amount of Ropivacaine consumed during the observation period of 24hours is calculated in milligrams